Wanrudee Isaranuwatchai


Director, Centre for Excellence in Economic Analysis Research


Dr. Wanrudee Isaranuwatchai is a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She is an Interim Director and a Health Economist at the Centre for Excellence in Economic Analysis Research (CLEAR), a part of the HUB Health Research Solutions at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Isaranuwatchai has collaborated with researchers and decision-makers in various topics areas to help communicate the value of health programs/initiatives using economic evidence. She has experience conducting economic evaluations using person-level data and decision modeling. Dr. Isaranuwatchai’s research focuses on applied economic evaluation (e.g., how to make economic evaluation more useful to researchers, health providers, and decision-makers) and health economics methods.

Recent Publications

  1. Isaranuwatchai, W, Li, R, Glassman, A, Teerawattananon, Y, Culye, AJ, Chalkidou, K et al.. Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy". Int J Health Policy Manag. 2018;8 (2):132-135. doi: 10.15171/ijhpm.2018.115. PubMed PMID:30980627 PubMed Central PMC6462203.
  2. Mighton, C, Carlsson, L, Clausen, M, Casalino, S, Shickh, S, McCuaig, L et al.. Development of patient "profiles" to tailor counseling for incidental genomic sequencing results. Eur. J. Hum. Genet. 2019; :. doi: 10.1038/s41431-019-0352-2. PubMed PMID:30846854 .
  3. McGillion, MH, Henry, S, Busse, JW, Ouellette, C, Katz, J, Choinière, M et al.. Examination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study. BMJ Open. 2019;9 (2):e022995. doi: 10.1136/bmjopen-2018-022995. PubMed PMID:30826789 PubMed Central PMC6398732.
  4. John-Baptiste, AA, Li, L, Isaranuwatchai, W, Osuch, E, Anderson, KK. Healthcare utilization costs of emerging adults with mood and anxiety disorders in an early intervention treatment program compared to a matched cohort. Early Interv Psychiatry. 2019; :. doi: 10.1111/eip.12790. PubMed PMID:30688032 .
  5. Tanaree, A, Assanangkornchai, S, Isaranuwatchai, W, Thavorn, K, Coyte, PC. Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis. PLoS ONE. 2019;14 (1):e0209210. doi: 10.1371/journal.pone.0209210. PubMed PMID:30601850 PubMed Central PMC6314591.
  6. Tan, MG, Isaranuwatchai, W, DeLyzer, T, Butler, K, Hofer, SOP, O'Neill, AC et al.. A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical breast reconstruction. J Surg Oncol. 2019;119 (3):388-396. doi: 10.1002/jso.25325. PubMed PMID:30562406 .
  7. Stevenson, JKR, Qiao, Y, Chan, KKW, Beca, J, Isaranuwatchai, W, Guo, H et al.. Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent. Leuk. Lymphoma. 2018; :1-9. doi: 10.1080/10428194.2018.1538509. PubMed PMID:30516081 .
  8. Tam, A, Mac, S, Isaranuwatchai, W, Bayley, M. Cost-effectiveness of a high-intensity rapid access outpatient stroke rehabilitation program. Int J Rehabil Res. 2019;42 (1):56-62. doi: 10.1097/MRR.0000000000000327. PubMed PMID:30431508 .
  9. Boodoo, C, Perry, JA, Leung, G, Cross, KM, Isaranuwatchai, W. Cost-effectiveness of telemonitoring screening for diabetic foot ulcer: a mathematical model. CMAJ Open. ;6 (4):E486-E494. doi: 10.9778/cmajo.20180088. PubMed PMID:30337474 PubMed Central PMC6201712.
  10. Pham, B, Bagheri, E, Rios, P, Pourmasoumi, A, Robson, RC, Hwee, J et al.. Improving the conduct of systematic reviews: a process mining perspective. J Clin Epidemiol. 2018;103 :101-111. doi: 10.1016/j.jclinepi.2018.06.011. PubMed PMID:30297037 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto